As filed with the Securities and
Exchange Commission on August 16, 2019
Registration No. 333-232194
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Amendment No. 1 to
FORM
S-3
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
Pareteum
Corporation
(Exact name of registrant as specified in charter)
Delaware
(State or other
jurisdiction of
incorporation or
organization)
|
|
95-4557538
(I.R.S. Employer
Identification No.)
|
1185 Avenue of the Americas, 37
th
Floor
New York, New York 10036
Telephone: (212) 984-1096
(Address, including zip code, and telephone
number,
including area code, of principal executive
offices)
Mr. Robert H. Turner
,
Chief
Executive Officer and Executive Chairman
1185 Avenue of the Americas, 37
th
Floor
New York, New York 10036
Telephone: (212) 984-1096
(Address, including zip code, and telephone
number,
1including area code, of agent for service)
Copies to:
Darrin Ocasio, Esq.
Sichenzia Ross Ference LLP
1185 Avenue of the Americas, 37
th
Floor
New York, New York 10036
Telephone: (212) 930-9700
Fax Number: (212) 930-9725
Approximate date of commencement of proposed
sale to the public:
From time to time after the effective date of this registration statement.
If
the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please
check the following box.
¨
If
any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415
under the Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans,
check the following box.
x
If
this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please
check the following box and list the Securities Act registration statement number of the earlier effective registration statement
for the same offering.
¨
If
this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and
list the Securities Act registration statement number of the earlier effective registration statement for the same offering.
¨
If
this Form is a registration statement pursuant to General Instruction I.D. or a post-effective amendment thereto that shall
become effective upon filing with the Commission pursuant to Rule 462(e) under the Securities Act, check the following box.
¨
If
this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.D. filed to register
additional securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the following
box.
¨
Indicate by check mark whether the registrant
is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company or an emerging growth company.
See definitions of "large accelerated filer", "accelerated filer", "smaller reporting company" and
"emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer
¨
|
|
Accelerated filer
x
|
|
Non-accelerated filer
¨
|
|
Smaller
reporting company
x
Emerging
growth company
¨
|
If an emerging growth company, indicate
by check mark if the registrant has elected not to use the extended transition period for complying with new or revised financial
accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act.
¨
CALCULATION OF REGISTRATION FEE
Title
of Each Class of Securities
to be Registered
|
|
Amount
to be
Registered
|
|
|
Proposed
Maximum
Offering Price Per
Share
|
|
|
Proposed
Maximum
Aggregate Offering
Price
|
|
|
Amount
of
Registration Fee
|
Common
Stock, par value $0.00001 per share
|
|
|
550,000(1)
|
|
|
|
$2.90(2)
|
|
|
|
$ 1,595,000
(2)
|
|
|
|
$193.31 (3)
|
|
(1)
|
Pursuant to Rule 416 under the Securities Act, the shares of common stock, par value $0.00001
per share ("Common Stock") being registered hereunder include such indeterminate number of shares of Common Stock as
may be issuable with respect to the shares of Common Stock being registered hereunder as a result of stock splits, stock dividends
or in connection with a stock combination, recapitalization, merger, consolidation or otherwise.
|
|
(2)
|
Estimated solely for the purpose of calculating
the registration fee, pursuant to Rule 457(c) under the Securities Act, based on the average of the high and low prices
reported for the shares of Common Stock as reported on the Nasdaq Capital Market on August 13, 2019.
|
The registrant hereby
amends this registration statement on such date or dates as may be necessary to delay its effective date until the registrant shall
file a further amendment that specifically states that this registration statement shall thereafter become effective in accordance
with Section 8(a) of the Securities Act or until the registration statement shall become effective on such date as the Securities
and Exchange Commission, acting pursuant to said Section 8(a), may determine.
The information in this
prospectus is not complete and may be changed. The selling stockholders may not sell these securities until the registration statement
filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and the
selling stockholders are not soliciting offers to buy these securities in any state or other jurisdiction where the offer or sale
is not permitted.
SUBJECT TO COMPLETION,
DATED AUGUST 16, 2019
PROSPECTUS
Pareteum Corporation
550,000 Shares
Common Stock
The selling stockholders named in this
prospectus under the heading "Selling Stockholders" may offer and sell up to an aggregate of 550,000 shares of our common
stock, par value $0.00001 per share ("Common Stock"), from time to time. We will not receive any of the proceeds from
the sale of the Common Stock by the selling stockholders.
The securities may be offered and sold
by the selling stockholders from time to time at fixed prices, at market prices or at negotiated prices, and may be offered and
sold to or through one or more underwriters, dealers or agents or directly to purchasers on a continuous or delayed basis. See
"Plan of Distribution."
Our Common Stock is currently listed
on the Nasdaq Capital Market under the symbol "TEUM." On August 14, 2019, the last reported sale price of our Common
Stock on the Nasdaq Capital Market was $2.88 per share.
You should read this prospectus and any
supplement carefully before you purchase any of our securities. You should rely only on the information contained or incorporated
by reference in this prospectus. We have not authorized any other person to provide you with different information.
Investing in these securities involves
risks, including those set forth in the "Risk Factors" section of the prospectus and of our most recent Annual Report
on Form 10-K filed with the Securities and Exchange Commission (the "SEC"), which is incorporated by reference into
this prospectus as well as any amendment or update to our risk factors reflected in subsequent filings with the SEC.
Neither the SEC nor any state securities
commission has approved or disapproved of these securities or determined if this prospectus is truthful and complete. Any representation
to the contrary is a criminal offense.
This prospectus is dated , 2019.
TABLE OF CONTENTS
ABOUT THIS PROSPECTUS
This prospectus is part of a registration
statement that we filed with the SEC. The selling stockholders named in this prospectus may from time to time offer and sell up
to an aggregate of 550,000 shares of our Common Stock in one or more offerings. This prospectus provides you with a general
description of the securities that the selling stockholders may offer and sell. You should carefully read this prospectus, together
with the more detailed information regarding our company and our Common Stock that appear elsewhere in this prospectus and any
applicable prospectus supplement, together with the additional information (including our financial statements and notes to those
statements) that we incorporate in this prospectus by reference (which we describe under the heading "Incorporation of Information
By Reference") before investing in any of the securities offered.
We have filed or incorporated by reference
exhibits to the registration statement of which this prospectus forms a part. You should read the exhibits carefully for provisions
that may be important to you.
Neither we nor any selling stockholder
has authorized any dealer, salesman or other person to give any information or to make any representation other than those contained
or incorporated by reference in this prospectus and any accompanying supplement to this prospectus. You should not assume that
the information in this prospectus or any prospectus accompanying supplement is accurate as of any date other than the date on
the front of those documents or that any document incorporated by reference is accurate as of any date other than its filing date.
You must not rely upon any information or representation not contained or incorporated by reference in this prospectus or any accompanying
prospectus supplement. This prospectus and any accompanying supplement to this prospectus do not constitute an offer to sell or
the solicitation of an offer to buy any securities other than the registered securities to which they relate, nor do this prospectus
and any accompanying supplement to this prospectus constitute an offer to sell or the solicitation of an offer to buy securities
in any jurisdiction to any person to whom it is unlawful to make such offer or solicitation in such jurisdiction.
WHERE YOU CAN FIND MORE INFORMATION
We file annual, quarterly and current reports,
proxy statements and other information with the SEC. The SEC maintains an Internet website at http://www.sec.gov that contains
reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC. Our SEC
filings are accessible through the Internet at that website. Our SEC reports and amendments to those reports are also available
for download, free of charge, as soon as reasonably practicable after these reports are filed with the SEC, at our website at www.pareteum.com.
The content contained in, or that can be accessed through, our website is not a part of this prospectus.
Unless the context indicates otherwise,
as used in this prospectus, the terms "Pareteum," "Company," "we," "us" and "our"
refer to Pareteum Corporation and its consolidated subsidiaries.
INCORPORATION OF INFORMATION BY REFERENCE
The SEC allows us to "incorporate
by reference" the information we file with it, which means that we can disclose important information to you by referring
you to those documents. The information incorporated by reference is considered to be part of this prospectus, and information
that we file later with the SEC will automatically update and supersede this information. We incorporate by reference the documents
listed below:
Our Annual Report on Form 10-K for the fiscal year ended December 31, 2018 that we filed with the SEC on March 18, 2019;
Our Quarterly Report on Form 10-Q for the quarter ended June 30, 2019 that we filed with the SEC on August 9, 2019;
Our Quarterly Report on Form 10-Q for the quarter ended March 31, 2019 that we filed with the SEC on May 10, 2019;
Our Current Reports on Form 8-K
filed with the SEC on
February 13,
2019
,
February 26, 2019,
March
12, 2019
,
May 24, 2019
,
July
18, 2019
, and on Form 8-K/A filed with the SEC on
March
12, 2019
and
June 13, 2019
The description of our Common Stock contained in
our registration statement on
Form 8-A
filed on November 30, 2011 (Registration no. 001-35360)
with the SEC, including any amendment or report filed for
the purpose of updating such description;
All documents filed by us with the SEC pursuant to
Sections 13(a), 13(c), 14 or 15(d) of the Securities Exchange Act of 1934, as amended (the "Exchange Act") after
the date of the initial filing of the registration statement of which this prospectus is a part and prior to the effectiveness
of such registration statement; and
All documents filed by us with the SEC pursuant to
Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act on or after the date of this prospectus and before we stop offering
the securities under this prospectus.
We will provide without charge to each
person, including any beneficial owner, to whom this prospectus is delivered, upon his or her written or oral request, a copy of
any or all documents referred to above which have been or may be incorporated by reference into this prospectus but not delivered
with this prospectus excluding exhibits to those documents unless they are specifically incorporated by reference into those documents.
You can request those documents from us, at no cost, by writing or telephoning us at: Pareteum Corporation, 1185 Avenue of the
Americas, 37
th
Floor, New York, NY 10036, (212) 984-1096, Attention: Edward O’Donnell.
The most recent information that we file
with the SEC automatically updates and supersedes older information. The information contained in any such filing will be deemed
to be a part of this prospectus, commencing on the date on which the filing is made.
Information furnished under Items 2.02
or 7.01 (or corresponding information furnished under Item 9.01 or included as an exhibit) in any past or future Current Report
on Form 8-K that we file with the SEC, unless otherwise specified in such report, is not incorporated by reference in this
prospectus.
CAUTIONARY NOTE REGARDING FORWARD-LOOKING
STATEMENTS
This prospectus contains forward looking
statements that involve risks and uncertainties. All statements other than statements of historical fact contained in this
prospectus, including statements regarding future events, our future financial performance, business strategy, and plans and objectives
of management for future operations, are forward-looking statements. We have attempted to identify forward-looking statements by
terminology including “anticipates,” “believes,” “can,” “continue,” “could,”
“estimates,” “expects,” “intends,” “may,” “plans,” “potential,”
“predicts,” “should,” or “will” or the negative of these terms or other comparable terminology.
Although we do not make forward looking statements unless we believe we have a reasonable basis for doing so, we cannot guarantee
their accuracy. These statements are only predictions and involve known and unknown risks, uncertainties and other factors, including
the risks outlined under “Risk Factors” or elsewhere in this prospectus, which may cause our or our industry’s
actual results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Moreover,
we operate in a highly regulated, very competitive, and rapidly changing environment. New risks emerge from time to time and it
is not possible for us to predict all risk factors, nor can we address the impact of all factors on our business or the extent
to which any factor, or combination of factors, may cause our actual results to differ materially from those contained in any forward-looking
statements.
We have based these forward-looking statements
largely on our current expectations and projections about future events and financial trends that we believe may affect our financial
condition, results of operations, business strategy, short term and long term business operations, and financial needs. These forward-looking
statements are subject to certain risks and uncertainties that could cause our actual results to differ materially from those reflected
in the forward looking statements. Factors that could cause or contribute to such differences include, but are not limited to,
those discussed in this prospectus, and in particular, the risks discussed below and under the heading “Risk Factors”
and those discussed in other documents we file with the SEC. The following discussion should be read in conjunction with the consolidated
financial statements for the fiscal years ended December 31, 2018 and 2017 and notes incorporated by reference therein, and the
consolidated financial statements for iPass Inc. for the fiscal years ended December 31, 2018 and 2017 and notes incorporated by
reference therein. We undertake no obligation to revise or publicly release the results of any revision to these forward-looking
statements, except as required by law. In light of these risks, uncertainties and assumptions, the forward-looking events and circumstances
discussed in this prospectus may not occur and actual results could differ materially and adversely from those anticipated or implied
in the forward-looking statement.
You should not place undue reliance on
any forward-looking statement, each of which applies only as of the date of this prospectus. You should be aware that the occurrence
of the events described in the section entitled “Risk Factors” and elsewhere in this prospectus could negatively affect
our business, operating results, financial condition and stock price. Except as required by law, we undertake no obligation to
update or revise publicly any of the forward-looking statements after the date of this prospectus to conform our statements to
actual results or changed expectations.
RISK FACTORS
Our business is influenced by many factors
that are difficult to predict, and that involve uncertainties that may materially affect actual operating results, cash flows and
financial condition. Before making an investment decision, you should carefully consider these risks set forth in the "Risk
Factors" section of our Annual Report on Form 10-K, as filed with the SEC on March 18, 2019 which is incorporated by
reference into this prospectus, as well as any amendment or update to our risk factors reflected in subsequent filings with the
SEC and any applicable prospectus supplement. You should also carefully consider any other information we include or incorporate
by reference in this prospectus. Any such risk could cause our business, financial condition or operating results to suffer. The
market price of our Common Stock could decline if one or more of these risks and uncertainties develop into actual events. You
could lose all or part of your investment.
PARETEUM CORPORATION
Overview
Pareteum Corporation (Nasdaq: TEUM) is
a rapidly growing cloud software communications platform company with a mission -
to connect every person and every(thing)
™.
Millions of people and devices are connected
around the world using Pareteum’s global cloud software communications platform, enhancing their mobile experience. Pareteum
unleashes the power of applications and mobile services, bringing secure, ubiquitous, scalable, and seamlessly available voice,
video, SMS/text messaging, and data services to our customers, making worldwide communications services easily and economically
accessible to everyone. By harnessing the value of our cloud communications platform, Pareteum serves enterprises, communications
service providers, early stage innovators, developers, Internet-of-Things (“IoT”), and telecommunications infrastructure
providers Pareteum envisions a new mobile communications experience imagining what will be, and delivering now.
With estimates of up to 30 billion
devices to be managed and connected the total available market is astoundingly large. Service providers, brand marketing companies,
enterprise and IoT providers use Pareteum to energize their growth and profitability through cloud communication services and
complete turnkey solutions featuring relevant content, applications, and connectivity worldwide. To achieve this, Pareteum has
developed, and added through its acquisition of Artilium plc, public limited company registered in England and Wales (“Artilium”)
and iPass Inc., patent pending software platforms which are connected to 59 mobile networks in 80 countries using multiple different
communications channels including mobile telephony, data, SMS, VOIP, OTT services – all over the world. Pareteum integrates
all these disparate communications methods and services and brings them to life for customers and application developers, allowing
communications to become value-added. This is a major strategic target for many industries, from legacy telecommunications providers
to the disruptive technology and data enterprises of today and the future.
The vast majority of our platform is
comprised of our self-developed software and intellectual property, which provides our customers with a great deal of flexibility
in how they use our products now and in the future and allows us to be market driven in our future. We have approximately
40 patents granted in relation to techniques and processes which support our cloud software and communications platform solutions.
Our platform services partners (technologies integrated into our cloud) include: HPE, IBM, Sonus, Oracle, Microsoft, NetNumber,
Affirmed and other world-class technology providers.
Pareteum is a mission focused company empowering
every person and every “thing” to be globally connected –
ANY
DEVICE, ANY NETWORK, ANYWHERE
™. The Pareteum cloud communications platform targets large and growing sectors
from IoT, Mobile Virtual Network Operators (MVNO), Smart Cities, and Application developer markets - each in need of mobile platforms,
management and connectivity. These sectors need Communications-Platform-as-a-Service (CPaaS), which Pareteum delivers. Our solutions
have received industry acclaim.
At Pareteum, our mission is to create an
easily accessible open mobility system for the world. We believe that open software and interfaces for mobility and applications
will create more innovation, economic freedom, and opportunity equality worldwide, just like the internet did for information.
The Pareteum Ecosystem
Our value proposition intersects with numerous
applications and industries. It is our strong belief that no other company in the CPaaS market offers similarly broad value in
such a comprehensive way. An easily accessible open mobility system for the world is difficult to get started because it requires
a “network effect”. The network effect is an observable condition that yields increased value to the “new easily
accessible open mobility system for the world”, and all users of the system as more users come on board. The essence of this
point is that every communication – a transaction – requires both a sender and recipient who are willing to access
and use the new system. We aim to provide the marketplace exchange on which these transactions take place, and will attract new
users.
Innovative Use Cases
Many sectors, from traditional network
operators to disruptive technology and data-driven companies, have found many innovative use cases for our platforms. Beyond simply
enabling communications between people and devices, the platforms of Pareteum enable:
|
Ø
|
Smart homes, including smart appliances, smart energy meters, wearables
etc.
|
|
Ø
|
Smart logistics and supply chains
|
|
Ø
|
Smart healthcare applications
|
In addition to the foregoing, as a result
of certain acquisitions completed in October 2018 and February 2019, the Company has acquired certain intellectual property portfolios,
which it now manages through various wholly-owned direct and indirect subsidiaries (the “Acquired IP Rights”). The
Company utilizes patent, copyright, trademark and trade secret laws in the United States, Europe, and elsewhere to protect the
Acquired IP Rights.
Business Model
At Pareteum, our mission is to create an
easily accessible open mobility system for the world. We believe that open software and interfaces for communications services
will create more innovation, economic freedom, and opportunity equality worldwide, just like the internet did for information.
However, an easily accessible open mobility
system for the world is challenging to scale because it requires a “network effect”. The network effect is the principle
that a service yields increased value as it grows. The essence of this point is that our business and our services will grow in
value as we grow and scale. We aim to achieve that growth by providing the marketplace exchange on which these communications and
transactions take place, and in doing so we attract new users and more customers.
To achieve our desired and rapid growth,
we are using our managed services solutions as a launching pad from which to grow our Global Cloud Services Platform and Application
Exchange & Developer Platform. This process is already well underway, including with our anchor customer Vodafone.
Go-to-Market and Growth Strategy
Pareteum is in fast-growth mode, which
will be achieved through a combination of organic growth as well as targeted and accretive mergers & acquisitions, such as
the recent acquisitions of Artilium and iPass, and the purchase of substantially all of the assets of Devicescape Software, Inc.,
as well as others that will be identified from time to time.
Pareteum continues to win new long-term
contractual business. We expect this pace to increase throughout 2019 and beyond. We see many new opportunities, including those
that leverage our support of emerging technologies, which is at the heart of our identity management and payment systems integration
plans.
Our focus is on selling and implementing
new communications services and IoT opportunities as fast as possible, as the world of connected devices and people continues to
rise on a daily basis.
We will measure our growth in the numbers
of “Connections” that we on-board to our platforms, be it SIM cards, handsets, devices, vehicles etc. As at December
31, 2018, we had approximately 4,609,000 Connections, an increase of 252% over the end of the prior year.
Our go-to-market strategy uses a four-phase
approach:
|
Phase 1:
|
We continue to attract new subscribers across all verticals to all our platforms through direct sales, existing channel partnerships and new initiatives such as referral programs.
|
|
Phase 2:
|
We will continue
to on-board new communication services providers, multiplying our own growth, largely through business development and direct
sales in each of our six defined sales regions (North America, Latin America, Europe, Middle East, Africa, and Asia-Pacific).
|
|
Phase 3:
|
We will drive adoption through a twin approach. First, we will be on-boarding more Connections which are already active on our Managed Services and Global Cloud Platforms, as our initial user base. Second, we will be drawing in new customers and end-users to the Application Exchange & Developer Platform. These will be people with the greatest pain point, who are underserved by the current mobility networks and applications (including in developing markets).
|
|
Phase 4:
|
At this stage, our strategic Application Exchange & Developer Platform customers will have their own go-to-market strategy, creating shared value, ranging from traditional consumer strategies to sophisticated B2B and B2B2C strategies, driving and expanding our ecosystem to new heights.
|
The phases described above are already
being implemented, in parallel as far as possible, for the fastest most sustainable growth. This highlights our strategy for accelerating
the world’s shift to an open mobility and application network. When we’re successful, it will accelerate the pace
of innovation in the world, create more economic freedom, and provide better mobility services to billions of underserved people.s
CORPORATE INFORMATION
Pareteum Corporation, a Delaware corporation,
was originally formed in 2001 as Elephant Talk Communications Corp. as a result of a merger between Staruni Corporation (USA, 1962)
and Elephant Talk Limited (Hong Kong, 1994).
In December 2011, the Company moved its
listing from the OTCBB to the NYSE MKT (now known as the NYSE American) and its stock began trading at that time under the ticker
symbol “ETAK”.
Following approval at the Company’s
2016 annual stockholder meeting, the Company was renamed Pareteum Corporation and on November 3, 2016, the Company started trading
on the Exchange under the current ticker symbol “TEUM”. On October 23, 2018, the company moved its listing to Nasdaq
under its current ticker symbol “TEUM”.
Pareteum currently has offices in North
America, South America, Spain, Bahrain, Singapore, Indonesia, Germany, Belgium, United Kingdom, Russia, Netherlands and India.
USE OF PROCEEDS
We will not receive any proceeds from the
sale of shares of our Common Stock by the selling stockholders named in this prospectus.
DESCRIPTION OF CAPITAL STOCK
Our authorized capital stock consists
of 500,000,000 shares of Common Stock and 50,000,000 shares of preferred stock, par value $0.00001 per share. As of August 14,
2019, 111,903,762 shares of our Common Stock, and no shares of our preferred stock, were outstanding.
Common Stock
Dividend Rights
Holders of the common stock may receive
dividends when, as and if declared by our board of directors out of the assets legally available for that purpose and subject to
the preferential dividend rights of any other classes or series of stock of our Company. We have never paid, and have no
plans to pay, any dividends on our shares of common stock.
Voting Rights
Holders of the common stock are entitled
to one vote per share in all matters as to which holders of common stock are entitled to vote. Holders of not less than a majority
of the outstanding shares of common stock entitled to vote at any meeting of stockholders constitute a quorum unless otherwise
required by law.
Election of Directors
Directors hold office until the next annual
meeting of stockholders and are eligible for re-election at such meeting. Directors are elected by a majority of the shares present
in person or represented by proxy at the meeting and entitled to vote on the election of directors, except that if the number of
director nominees exceeds the number of directors to be elected, directors are elected by a plurality of the shares present in
person or represented by proxy at the meeting and entitled to vote on the election of directors. There is no cumulative voting
for directors.
Liquidation
In the event of any liquidation, dissolution
or winding up of the Company, holders of the common stock have the right to receive ratably and equally all of the assets remaining
after payment of liabilities and liquidation preferences of any preferred stock then outstanding.
Redemption
The common stock is not redeemable or convertible
and does not have any sinking fund provisions.
Preemptive Rights
Holders of the common stock do not have preemptive rights.
Other Rights
Our common stock is not liable to further
calls or to assessment by the registrant and for liabilities of the registrant imposed on its stockholders under state statutes.
Right to Amend Bylaws
The board of directors has the power to
adopt, amend or repeal the bylaws. Bylaws adopted by the board of directors may be repealed or changed, and new bylaws made,
by the stockholders, and the stockholders may prescribe that any bylaw made by them shall not be altered, amended or repealed by
the board of directors.
Change in Control
Provisions of Delaware law and our certificate
of incorporation and bylaws could make the acquisition of our company by means of a tender offer, proxy contest or otherwise, and
the removal of incumbent officers and directors, more difficult. These provisions include:
Section 203 of the General Corporation
Law of the State of Delaware (the “DGCL”), which prohibits a merger with a 15%-or-greater stockholder, such as a party
that has completed a successful tender offer, until three years after that party became a 15%-or-greater stockholder; and
The authorization in our certificate of
incorporation of undesignated preferred stock, which could be issued without stockholder approval in a manner designed to prevent
or discourage a takeover.
Together, these provisions may make the
removal of management more difficult and may discourage transactions that could otherwise involve payment of a premium over prevailing
market prices for our common stock.
Market, Symbol and Transfer Agent
Our common stock is listed for trading
on the Nasdaq under the symbol “TEUM”. The transfer agent and registrar for our common stock is Continental Stock Transfer and
Trust Company.
Preferred Stock
Our certificate of incorporation, as
amended, empowers our board of directors, without action by our stockholders, to issue up to 50,000,000 shares of preferred stock
from time to time in one or more series, which preferred stock may be offered by this prospectus and supplements thereto.
Our board has the right to fix the rights,
preferences, privileges and restrictions of our authorized but undesignated preferred stock of each series in the certificate of
designation relating to that series. We will file as an exhibit to the registration statement of which this prospectus is a part,
or will incorporate by reference from a current report on Form 8-K that we file with the SEC, the form of any certificate of designation
that describes the terms of the series of preferred stock we are offering before the issuance of the related series of preferred
stock. This description will include any or all of the following, as required:
|
·
|
the title and stated value;
|
|
·
|
the number of shares we are offering;
|
|
·
|
the liquidation preference per share;
|
|
·
|
the dividend rate, period and payment date and method of calculation for dividends;
|
|
·
|
whether dividends will be cumulative or non-cumulative and, if cumulative, the date from which dividends will accumulate;
|
|
·
|
any contractual limitations on our ability to declare, set aside or pay any dividends;
|
|
·
|
the procedures for any auction and remarketing, if any;
|
|
·
|
the provisions for a sinking fund, if any;
|
|
·
|
the provisions for redemption or repurchase, if applicable, and any restrictions on our ability to exercise those redemption and repurchase rights;
|
|
·
|
any listing of the preferred stock on any securities exchange or market;
|
|
·
|
whether the preferred stock will be convertible into our common stock, and, if applicable, the conversion price, or how it will be calculated, and the conversion period;
|
|
·
|
whether the preferred stock will be exchangeable into debt securities, and, if applicable, the exchange price, or how it will be calculated, and the exchange period;
|
|
·
|
voting rights, if any, of the preferred stock;
|
|
·
|
preemptive rights, if any;
|
|
·
|
restrictions on transfer, sale or other assignment, if any;
|
|
·
|
whether interests in the preferred stock will be represented by depositary shares;
|
|
·
|
a discussion of any material or special United States federal income tax considerations applicable to the preferred stock;
|
|
·
|
the relative ranking and preferences of the preferred stock as to dividend rights and rights if we liquidate, dissolve or wind up our affairs;
|
|
·
|
any limitations on issuance of any class or series of preferred stock ranking senior to or on a parity with the series of preferred stock as to dividend rights and rights if we liquidate, dissolve or wind up our affairs; and
|
|
·
|
any other specific terms, preferences, rights or limitations of, or restrictions on, the preferred stock.
|
If we issue shares
of preferred stock under this prospectus, after receipt of payment therefor, the shares will be fully paid and non-assessable.
The Delaware General
Corporation Law provides that the holders of preferred stock will have the right to vote separately as a class on any proposal
involving fundamental changes in the rights of holders of that preferred stock. This right is in addition to any voting rights
provided for in the applicable certificate of designation.
Our board of directors
may authorize the issuance of preferred stock with voting or conversion rights that could adversely affect the voting power or
other rights of the holders of our common stock. Preferred stock could be issued quickly with terms designed to delay or prevent
a change in control of our Company or make removal of management more difficult. Additionally, the issuance of preferred stock
could have the effect of decreasing the market price of our common stock.
Options and Warrants
As of August 15, 2019, we had:
|
·
|
8,746,023 shares of Common Stock issuable upon the exercise of
stock options outstanding with a weighted average exercise price of approximately $2.26 per share;
|
|
·
|
3,173,713 shares of Common Stock issuable upon the exercise of
outstanding or issuable warrants with a weighted average exercise price of approximately $2.21 per share.
|
SELLING STOCKHOLDERS
The selling stockholders named below
may offer to sell from time to time in the future up to an aggregate of 550,000 shares of our Common Stock, which were previously
acquired by such stockholders as further described below.
On April 22, 2019, the Company, together
with Devicescape Holdings, Inc., a Delaware corporation and wholly-owned subsidiary of the Company (the “Holdco” and
together with the Company, the “Buyer”) entered into an asset purchase agreement (the “Purchase Agreement”)
with Devicescape Software, Inc., a California corporation (“Devicescape”), whereby the Holdco acquired substantially
all of the assets of Devicescape, including certain technology that the Company’s subsidiary, iPass, licenses from Devicescape
and certain account receivables owed by iPass and other third parties to Devicescape. In addition to the acquisition of
Devicescape’s assets, Holdco assumed certain of its liabilities. In connection with the acquisition and assumption,
and pursuant to the terms and subject to the conditions set forth in the Purchase Agreement, the Company paid cash consideration
of $2,000,000, immediately paid off a debt obligation equal to $67,058 owed by Devicescape in order to unencumber certain assets,
and issued to Devicescape an aggregate of 400,000 shares of the Company’s common stock.
On May 29, 2019, the Company issued Ali
Davachi 150,000 shares as compensation for software development services.
Unless otherwise indicated, each selling
stockholder has sole voting and investment power with respect to its shares of Common Stock. All of the information contained in
the table below is based solely upon information provided to us by the selling stockholders or otherwise known by us. In addition
to the shares offered hereby, the selling stockholders may otherwise beneficially own our shares of Common Stock as a result of,
among others, open market purchases, which information is not obtainable by us without undue effort and expense. The selling stockholders
may have sold, transferred or otherwise disposed of, or may sell, transfer or otherwise dispose of, at any time or from time to
time since the date on which the information regarding the shares beneficially owned was last known by us, all or a portion of
the shares beneficially owned in transactions exempt from the registration requirements of the Securities Act.
Information concerning the selling stockholders
may change from time to time and any changed information will be set forth in supplements to this prospectus, if and when necessary.
The selling stockholders may offer all, some or none of their shares of Common Stock. We cannot advise you as to whether the selling
stockholders will in fact sell any or all of such shares of Common Stock.
The number of shares outstanding and
the percentages of beneficial ownership are based on 111,903,762 shares of our Common Stock outstanding as of August 14, 2019.
For the purposes of the following table,
the number of shares of our Common Stock beneficially owned has been determined in accordance with Rule 13d-3 under the Exchange
Act, and such information is not necessarily indicative of beneficial ownership for any other purpose. Under Rule 13d-3, beneficial
ownership includes any shares as to which the selling stockholders have sole or shared voting power or investment power and also
any shares which that selling stockholders have the right to acquire within 60 days of the date of this prospectus through
the exercise of any stock option.
|
|
Number
of Shares
Beneficially
Owned Prior to
the Offering
|
|
|
Number
of
|
|
|
Number
of Shares
Beneficially
Owned After
the Offering(1)
|
|
Name
of Selling Stockholders
|
|
Number
|
|
|
Percentage
|
|
|
Shares
Offered
|
|
|
Number
|
|
|
Percentage
|
|
Devicescape
Software, Inc.
|
|
|
400,000
|
|
|
|
*
|
|
|
|
400,000
|
|
|
|
0
|
|
|
|
0
|
|
Ali
Davachi
|
|
|
150,000
|
|
|
|
*
|
|
|
|
150,000
|
|
|
|
0
|
|
|
|
0
|
|
|
*
|
Represents less than 1%.
|
|
(1)
|
Assumes that all shares registered hereunder will be sold by the selling stockholders and that the selling stockholders do
not acquire any additional shares.
|
PLAN OF DISTRIBUTION
The Common Stock offered by this prospectus
is being offered by the selling stockholders. The Common Stock may be sold or distributed from time to time by the selling stockholders
directly to one or more purchasers or through brokers, dealers, or underwriters who may act solely as agents at market prices prevailing
at the time of sale, at prices related to the prevailing market prices, at negotiated prices, or at fixed prices, which may be
changed. The sale of the Common Stock offered by this prospectus may be effected in one or more of the following methods:
|
·
|
ordinary brokers' transactions;
|
|
·
|
transactions involving cross or block
trades;
|
|
·
|
through brokers, dealers, or underwriters
who may act solely as agents;
|
|
·
|
in other ways not involving market makers
or established business markets, including direct sales to purchasers or sales effected through agents;
|
|
·
|
in privately negotiated transactions;
or
|
|
·
|
any combination of the foregoing.
|
The selling stockholders may also sell
shares of common stock under Rule 144 promulgated under the Securities Act, if available, rather than under this prospectus.
In addition, the selling stockholders may transfer the shares of common stock by other means not described in this prospectus.
Brokers, dealers, underwriters, or agents
participating in the distribution of the shares as agents may receive compensation in the form of commissions, discounts, or concessions
from the selling stockholders and/or purchasers of the common stock for whom the broker-dealers may act as agent.
The selling stockholders are "underwriters"
within the meaning of the Securities Act.
Neither we nor the selling stockholders
can presently estimate the amount of compensation that any agent will receive. We know of no existing arrangements between the
selling stockholders, any other stockholders, broker, dealer, underwriter, or agent relating to the sale or distribution of the
shares offered by this prospectus. At the time a particular offer of shares is made, a prospectus supplement, if required, will
be distributed that will set forth the names of any agents, underwriters, or dealers and any compensation from the selling stockholders,
and any other required information.
Insofar as indemnification for liabilities
arising under the Securities Act may be permitted to our directors, officers, and controlling persons, we have been advised that
in the opinion of the SEC this indemnification is against public policy as expressed in the Securities Act and is therefore, unenforceable.
We may suspend the sale of shares by the
selling stockholders pursuant to this prospectus for certain periods of time for certain reasons, including if the prospectus is
required to be supplemented or amended to include additional material information.
EXPERTS
The consolidated financial statements as
of December 31, 2018 and 2017 and for each of the years in the two-year period ended December 31, 2018 and the effectiveness of
internal control over financial reporting as of December 31, 2018 incorporated in this prospectus by reference from the Pareteum
Corporation Annual Report on Form 10-K for the year ended December 31, 2018 have been audited by Squar Milner LLP, an independent
registered public accounting firm, as stated in their reports thereon (which report expresses an unqualified opinion for the audit
of our consolidated financial statements and a qualified opinion on the effectiveness of our internal controls over financial reporting),
incorporated herein by reference, and have been incorporated in this Prospectus and Registration Statement in reliance upon such
reports and upon the authority of such firm as experts in accounting and auditing.
The report of Squar Milner LLP dated March
18, 2019, on the effectiveness of internal control over financial reporting as of December 31, 2018, expressed an opinion that
Pareteum Corporation had not maintained effective internal control over financial reporting as of December 31, 2018, based on criteria
established in
Internal Control — Integrated Framework
issued by the Committee of Sponsoring Organizations
of the Treadway Commission in 2013.
The consolidated financial statements
of iPass as of December 31, 2017 and for the year then ended incorporated by reference in this prospectus and elsewhere in the
registration statement have been so included in reliance upon the report of Grant Thornton LLP, independent registered public
accountants (the report on the consolidated financial statements contains explanatory paragraphs regarding the company’s
ability to continue as a going concern), upon the authority of said firm as experts in accounting and auditing.
The consolidated financial statements of iPass as of December
31, 2018 and for the year then ended incorporated by reference in this Prospectus have been so incorporated in reliance on the
report of BDO USA, LLP, independent auditor (the report on the consolidated financial statements contains explanatory paragraphs
regarding the company’s ability to continue as a going concern and change in accounting principle related to revenue recognition),
given on the authority of said firm as experts in auditing and accounting.
LEGAL MATTERS
The validity of the securities being offered
by this prospectus will be passed upon by Sichenzia Ross Ference LLP, New York, New York.
PART II
Information Not Required in Prospectus
Item 14. Other Expenses of Issuance
and Distribution
The following table sets forth the
expenses to be incurred by us in connection with the registration, issuance and distribution of the securities described in this
registration statement being registered hereby.
SEC registration fee
|
|
$
|
211
|
|
Legal fees and expenses
|
|
$
|
10,000
|
|
Accounting fees and expenses
|
|
$
|
10,000
|
|
Transfer agent and
miscellaneous expenses
|
|
$
|
2,000
|
|
Total
|
|
$
|
22,211
|
|
Item 15. Indemnification of Directors
and Officers
Section 145 of the DGCL empowers
a Delaware corporation to indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending
or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (other than an action by or
in the right of such corporation) by reason of the fact that such person is or was a director, officer, employee or agent of such
corporation, or is or was serving at the request of such corporation as a director, officer, employee or agent of another corporation
or enterprise. A corporation may, in advance of the final disposition of any civil, criminal, administrative or investigative
action, suit or proceeding, pay the expenses (including attorneys’ fees) incurred by any officer, director, employee or
agent in defending such action, provided that the director or officer undertakes to repay such amount if it shall ultimately be
determined that he or she is not entitled to be indemnified by the corporation. A corporation may indemnify such person against
expenses (including attorneys’ fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by
such person in connection with such action, suit or proceeding if he acted in good faith and in a manner he or she reasonably
believed to be in or not opposed to the best interests of the corporation, and, with respect to any criminal action or proceeding,
had no reasonable cause to believe his conduct was unlawful.
A Delaware corporation may indemnify officers
and directors in an action by or in the right of the corporation to procure a judgment in its favor under the same conditions,
except that no indemnification is permitted without judicial approval if the officer or director is adjudged to be liable to the
corporation. Where an officer or director is successful on the merits or otherwise in the defense of any action referred to above,
the corporation must indemnify him or her against the expenses (including attorneys’ fees) that he or she actually and reasonably
incurred in connection therewith. The indemnification provided is not deemed to be exclusive of any other rights to which an officer
or director may be entitled under any corporation’s bylaws, agreement, vote or otherwise.
In accordance with Section 145
of the DGCL, Article XI, Section 23 of Pareteum’s bylaws, Pareteum shall indemnify its directors, officers, employees
or other agents to the fullest extent not prohibited by the DGCL or any other applicable law. Pareteum may enter into individual
contracts with its directors and, to the fullest extent permitted by law, provide for additional contractual indemnification rights;
and, provided, further, that Pareteum shall not be required to indemnify any director in connection with any proceeding (or part
thereof) initiated by such person unless (i) such indemnification is expressly required to be made by law, (ii) the proceeding
was authorized by the board of Pareteum, (iii) such indemnification is provided by Pareteum, in its sole discretion, pursuant
to the powers vested in Pareteum under the DGCL or any other applicable law or (iv) such indemnification is required to be made
under subsection (d) of the bylaws. The board of Pareteum shall have the power to delegate the determination of whether indemnification
shall be given to any such person, to such officers or other persons as the board shall determine. Where an officer or director
is successful on the merits or otherwise in the defense of any action referred to above, Pareteum must indemnify him or her against
the expenses (including attorneys’ fees) that he or she actually and reasonably incurred in connection therewith. The rights
conferred by the bylaws are not exclusive of any other right which such person may have or thereafter acquire under any applicable
statute, provision of the bylaws, agreements, vote of the stockholders or directors or otherwise. The foregoing is a summary of
Article XI of Pareteum’s bylaws and is qualified in its entirety by reference to Pareteum’s bylaws which are
attached as Exhibit 3.3 hereto.
Pareteum has entered into indemnification
agreements with its executive officers and directors which requires Pareteum, among other things, to (i) indemnify such indemnitees
to the fullest extent permitted by law for certain expenses incurred in a proceeding arising out of the indemnitee’s service
as a director or officer of Pareteum or of another company or enterprise at the request of Pareteum and (ii) advance such expenses
to the indemnitee.
Pareteum also maintains directors’
and officers’ liability insurance. Insofar as the indemnification for liabilities arising under the Securities Act, may be
permitted to Pareteum’s directors, officers or controlling persons pursuant to the foregoing provisions, Pareteum has been
informed that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is,
therefore, unenforceable.
Item 16. Exhibits
A list of exhibits filed herewith is contained in the exhibit
index that immediately precedes such exhibits and is incorporated herein by reference.
Item 17. Undertakings
The undersigned registrant hereby undertakes:
|
(1)
|
To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:
|
(i) To include any prospectus required by section 10(a)(3) of the Securities Act;
(ii) To
reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent
post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set
forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if
the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high
end of the estimated maximum offering range may be reflected in the form of prospectus filed with the SEC pursuant to Rule 424(b)
if, in the aggregate, the changes in volume and price represent no more than 20% change in the maximum aggregate offering price
set forth in the "Calculation of Registration Fee" table in the effective registration statement; and
(iii) To
include any material information with respect to the plan of distribution not previously disclosed in the registration statement
or any material change to such information in the registration statement;
provided, however,
that paragraphs (i),
(ii) and (iii) do not apply if the information required to be included in a post-effective amendment by those paragraphs
is contained in reports filed with or furnished to the SEC by the registrant pursuant to Section 13 or Section 15(d)
of the Exchange Act that are incorporated by reference in the registration statement, or is contained in a form of prospectus filed
pursuant to Rule 424(b) that is part of the registration statement.
(2) That,
for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be
a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall
be deemed to be the initial bona fide offering thereof.
(3) To remove
from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination
of the offering.
(4) That,
for the purpose of determining liability under the Securities Act to any purchaser:
(A) Each
prospectus filed by the registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as
of the date the filed prospectus was deemed part of and included in the registration statement; and
(B) Each
prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5) or (b)(7) as part of a registration statement in
reliance on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (vii) or (x) for the
purpose of providing the information required by Section 10(a) of the Securities Act shall be deemed to be part of and
included in the registration statement as of the earlier of the date such form of prospectus is first used after
effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus. As
provided in Rule 430B, for liability purposes of the issuer and any person that is at that date an underwriter, such
date shall be deemed to be a new effective date of the registration statement relating to the securities in the registration
statement to which the prospectus relates, and the offering of such securities at that time shall be deemed to be the initial
bona fide offering thereof.
Provided
,
however
, that no statement made in a registration statement or
prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference
into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time
of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration
statement or prospectus that was part of the registration statement or made in any such document immediately prior to such
effective date; or
(5) That,
for purposes of determining any liability under the Securities Act, each filing of the registrant's annual report pursuant to Section 13(a)
or 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan's annual report pursuant to Section 15(d)
of the Exchange Act) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement
relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial
bona fide offering thereof.
(6) Insofar
as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons
of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the
SEC such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a
claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a
director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted
by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless
in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction
the question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final
adjudication of such issue.
EXHIBIT INDEX
Number
|
|
Description
|
|
|
|
2.1
|
|
Agreement and Plan of Merger between Pareteum Communication Corporation a Delaware Corporation and Pareteum Communications, Inc., a California Corporation (incorporated by reference to Appendix A to Pareteum Corporation’s Definitive Proxy Statement filed dated July 26, 2011).
|
|
|
|
2.2
|
|
Rule 2.7 Announcement dated June 7, 2018 (incorporated by reference to Exhibit 2.1 to Pareteum Corporation’s current report on Form 8-K dated June 7, 2018).
|
|
|
|
2.3
|
|
Co-operation Agreement, dated June 7, 2018 (incorporated by reference to Exhibit 2.2 to Pareteum Corporation’s current report on Form 8-K dated June 7, 2018).
|
|
|
|
2.4
|
|
Sale and Purchase Agreement, dated March 17, 2010, by and among Pareteum Corporation and the stockholders of ValidSoft Limited other than Enterprise Ireland (incorporated by reference to Exhibit 2.1 to Pareteum Corporation’s current report on Form 8-K dated March 23, 2010).
|
|
|
|
2.5
|
|
Agreement and Plan of Merger by and among iPass Inc., TBR, Inc. and Pareteum Corporation dated November 12, 2018 (incorporated by reference to Pareteum Corporation’s current report on Form 8-k dated November 13, 2018).
|
|
|
|
3.1
|
|
Certificate of Merger (incorporated by reference to Exhibit 3.2 to Pareteum Corporation’s current report on Form 8-K dated October 4, 2011).
|
|
|
|
3.2
|
|
Certificate of Incorporation of Pareteum Communication Corporation, a Delaware Corporation (incorporated by reference to Exhibit 3.2 to Pareteum Corporation’s annual report on Form 10-K for the fiscal year ended December 31, 2013).
|
|
|
|
3.3
|
|
By-Laws (incorporated by reference to Appendix C of Pareteum Corporation’s Definitive Proxy Statement on Schedule 14A dated July 26, 2011).
|
|
|
|
3.4
|
|
Certificate of Amendment to Certificate of Incorporation (incorporated by reference to Exhibit 3.1 to Pareteum Corporation’s current report on Form 8-K dated August 29, 2016).
|
|
|
|
3.5
|
|
Certificate of Designation of Preferences, Rights and Limitations of Series A Preferred Stock as corrected (incorporated by reference to Exhibit 3.1 to Pareteum Corporation’s current report on Form 8-K dated September 9, 2016).
|
|
|
|
3.6
|
|
Certificate of Designation of Preferences, Rights and Limitations of Series A-1 Preferred Stock (incorporated by reference to Exhibit 3.1 to Pareteum Corporation’s current report on Form 8-K dated November 3, 2016).
|
|
|
|
3.7
|
|
Certificate of Amendment to Certificate of Incorporation (incorporated by reference to Exhibit 3.2 to Pareteum Corporation’s current report on Form 8-K dated November 3, 2016).
|
|
|
|
3.8
|
|
Certificate of Amendment to Certificate of Incorporation (incorporated by reference to Exhibit 3.1 to Pareteum Corporation’s current report on Form 8-K dated February 27, 2017).
|
|
|
|
3.9
|
|
Certificate of Designations, Preferences and Rights of Series B Convertible Preferred Stock (incorporated by reference to Exhibit 3.1 to Pareteum Corporation’s current report on Form 8-K dated November 8, 2017).
|
|
|
|
4.1
|
|
Form of Warrant, dated November 17, 2014, issued to Corbin Mezzanine Fund I, L.P. (incorporated by reference to Exhibit 4.1 to Pareteum Corporation’s current report on Form 8-K filed on November 21, 2014).
|
|
|
|
4.2
|
|
Form of Conversion Letter Agreement, dated November 17, 2014, issued to Saffelberg Investments NV (incorporated by reference to Exhibit 4.2 to Pareteum Corporation’s current report on Form 8-K filed on November 21, 2014).
|
|
|
|
4.3
|
|
Form of Warrant, dated November 17, 2014, issued to Saffelberg Investments NV (incorporated by reference to Exhibit 4.3 to Pareteum Corporation’s current report on Form 8-K filed on November 21, 2014).
|
|
|
|
4.4
|
|
Form of Warrant, dated July 9, 2015, issued to Corbin Mezzanine Fund I, L.P (incorporated by reference to Exhibit 4.1 to Pareteum Corporation’s current report on Form 8-K filed on July 14, 2014).
|
|
|
|
4.5
|
|
Form of Warrant, dated July 9, 2015, issued to Corbin Mezzanine Fund I, L.P (incorporated by reference to Exhibit 4.2 to Pareteum Corporation’s current report on Form 8-K filed on July 14, 2014).
|
|
|
|
4.6
|
|
Form of Warrant issued in the 9% Unsecured Subordinated Convertible Promissory Note Financing (incorporated by reference to Exhibit 4.1 to Pareteum Corporation’s current report on Form 8-K filed on December 24, 2015).
|
|
|
|
4.7
|
|
Corbin Warrant, dated December 27, 2016 issued to Corbin Mezzanine Fund I, L.P to purchase 27,051,627 shares of Common Stock (incorporated by reference to Exhibit 4.1 to Pareteum Corporation’s current report on Form 8-K filed on December 29, 2016).
|
|
|
|
4.8
|
|
ACM Warrant, dated December 27, 2016 issued to ACM Carry-I LLC to purchase 4,773,817 shares of Common Stock (incorporated by reference to Exhibit 4.2 to Pareteum Corporation’s current report on Form 8-K filed on December 29, 2016).
|
4.9
|
|
Amendment No. 1 to Corbin Warrant, dated March 31, 2017 (incorporated by reference to Exhibit 4.1 to Pareteum Corporation’s current report on Form 8-K filed on April 6, 2017).
|
|
|
|
4.10
|
|
Amendment No. 1 to ACM Warrant, dated March 31, 2017 (incorporated by reference to Exhibit 4.2 to Pareteum Corporation’s current report on Form 8-K filed on April 6, 2017).
|
|
|
|
4.11
|
|
Form of New Warrant (incorporated by reference to Exhibit 4.1 to Pareteum Corporation’s current report on Form 8-K filed on July 17, 2017).
|
|
|
|
4.12
|
|
Form of Warrant (incorporated by reference to Exhibit 4.1 to Pareteum Corporation’s current report on Form 8-K filed on December 1, 2017).
|
|
|
|
4.13
|
|
Form of Warrant (incorporated by reference to Exhibit 4.1 to Pareteum Corporation’s current report on Form 8-K filed on February 13, 2019
|
|
|
|
5.1
|
|
Opinion of Sichenzia Ross Ference*
|
|
|
|
10.1
|
|
Contract between Vodafone Enabler Espana, S.L. and Pareteum Europe Holding, B.V., dated November 1, 2013 (incorporated by reference to Exhibit 10.11 to Pareteum Corporation’s annual report on Form 10-K for the fiscal year ended December 31, 2013).
|
|
|
|
10.6
|
|
Release and Settlement Agreement, dated as of June 12, 2015, by and between Pareteum de Mexico, S.A.P.I. de C.V., Pareteum Europe Holding BV, and Pareteum Corporation, and Iusacell, S.A., de C.V. (incorporated by reference to Exhibit 10.1 to Pareteum Corporation’s current report on Form 8-K filed on June 16, 2015).
|
|
|
|
10.7
|
|
Severance Agreement, dated as of November 16, 2015, between Pareteum Corporation and Steven van der Velden (incorporated by reference to Exhibit 10.1 to Pareteum Corporation’s current report on Form 8-K filed on November 17, 2015).
|
|
|
|
10.8
|
|
Form of Subscription Agreement issued in the 9% Unsecured Subordinated Convertible Promissory Note Financing (incorporated by reference to Exhibit 10.1 to Pareteum Corporation’s current report on Form 8-K filed on December 24, 2015).
|
|
|
|
10.9
|
|
Form of 9% Unsecured Subordinated Convertible Promissory Note issued in the 9% Unsecured Subordinated Convertible Promissory Note Financing (incorporated by reference to Exhibit 10.2 to Pareteum Corporation’s current report on Form 8-K filed on December 24, 2015).
|
|
|
|
10.10
|
|
Amended and Restated Pareteum Corporation 2008 Long-Term Incentive Compensation Plan (incorporated by reference to Annex A to t Pareteum Corporation’s definitive proxy statement on Schedule 14 A filed on November 21, 2013).
|
|
|
|
10.12
|
|
Subscription Agreement (incorporated by reference to Exhibit 3.1 to Pareteum Corporation’s current report on Form 8-K dated September 9, 2016).
|
|
|
|
10.13
|
|
Form of Share Purchase Agreement dated September 30, 2016 (incorporated by reference to Exhibit 10.1 to Pareteum Corporation’s current report on Form 8-K dated October 6, 2016).
|
|
|
|
10.14
|
|
Promissory Note dated September 30, 2016 (incorporated by reference to Exhibit 10.2 to Pareteum Corporation’s current report on Form 8-K dated October 6, 2016).
|
|
|
|
10.15
|
|
License Agreement dated September 30, 2016 (incorporated by reference to Exhibit 10.3 to Pareteum Corporation’s current report on Form 8-K dated October 6, 2016).
|
|
|
|
10.16
|
|
Subscription Agreement (incorporated by reference to Exhibit 10.1 to Pareteum Corporation’s current report on Form 8-K dated November 3, 2016).
|
|
|
|
10.17
|
|
Letter Agreement (incorporated by reference to Exhibit 10.1 to Pareteum Corporation’s current report on Form 8-K dated December 21, 2016).
|
|
|
|
10.21
|
|
Agreement, dated March 30, 2017 (incorporated by reference to Exhibit 10.1 to Pareteum Corporation’s current report on Form 8-K dated March 31, 2017).
|
|
|
|
10.22
|
|
Amendment, dated March 31, 2017 (incorporated by reference to Exhibit 10.1 to Pareteum Corporation’s current report on Form 8-K dated April 6, 2017).
|
|
|
|
10.23
|
|
Form of Warrant Exercise Agreement (incorporated by reference to Exhibit 10.1 to Pareteum Corporation’s current report on Form 8-K dated July 17, 2017).
|
|
|
|
10.24
|
|
Pareteum Corporation 2017 Long-Term Incentive Compensation Plan (incorporated by reference to Appendix A to Pareteum Corporation’s definitive proxy statement on Schedule 14 A filed on July 27, 2017).
|
|
|
|
10.25
|
|
Placement Agency Agreement, dated October 5, 2017, between Pareteum Corporation and Dawson James Securities, Inc. (incorporated by reference to Exhibit 10.1 to Pareteum Corporation’s current report on Form 8-K dated October 5, 2017).
|
|
|
|
10.26
|
|
Form of Share Exchange Agreement (incorporated by reference to Exhibit 10.1 to Pareteum Corporation’s current report on Form 8-K dated October 16, 2017).
|
|
|
|
10.27
|
|
Form of Strategic Alliance Agreement (incorporated by reference to Exhibit 10.2 to Pareteum Corporation’s current report on Form 8-K dated October 16, 2017).
|
|
|
|
10.28
|
|
Form of Purchase Agreement (incorporated by reference to Exhibit 10.1 to Pareteum Corporation’s current report on Form 8-K dated December 1, 2017).
|
10.29
|
|
Form of Placement Agreement (incorporated by reference to Exhibit 10.2 to Pareteum Corporation’s current report on Form 8-K dated December 1, 2017).
|
|
|
|
10.30
|
|
Form of Purchase Agreement (incorporated by reference to Exhibit 10.1 to Pareteum Corporation’s current report on Form 8-K dated May 9, 2018).
|
|
|
|
10.31
|
|
Form of Placement Agreement (incorporated by reference to Exhibit 10.2 to Pareteum Corporation’s current report on Form 8-K dated May 9, 2018).
|
|
|
|
10.32
|
|
Management Services Agreement (incorporated by reference to Exhibit 10.1 to Pareteum Corporation’s current report on Form 8-K dated June 7, 2018).
|
|
|
|
10.33
|
|
Amendment dated June 7, 2018 to Management Services Agreement (incorporated by reference to Exhibit 10.2 to Pareteum Corporation’s current report on Form 8-K dated June 7, 2018).
|
|
|
|
10.34
|
|
Consent and Amendment No. 1 to Credit Agreement by and among iPass Inc., iPass IP LLC, Fortress Credit Corp., FIP UST LP and DBD Credit Funding LLC (incorporated by reference to Exhibit 10.1 to Pareteum Corporation’s current report on Form 8-K dated February 13, 2019).
|
|
|
|
10.35
|
|
Joinder to Security Agreement by Pareteum Corporation (incorporated by reference to Exhibit 10.2 to Pareteum Corporation’s current report on Form 8-K dated February 13, 2019).
|
|
|
|
10.36
|
|
Joinder to Guarantee by Pareteum Corporation (incorporated by reference to Exhibit 10.3 to Pareteum Corporation’s current report on Form 8-K dated February 13, 2019).
|
|
|
|
10.37
|
|
Joinder to Pledge Agreement by Pareteum Corporation (incorporated by reference to Exhibit 10.4 to Pareteum Corporation’s current report on Form 8-K dated February 13, 2019).
|
|
|
|
10.38***
|
|
Credit Agreement between Pareteum Corporation and certain subsidiaries of Pareteum Corporation, Post Road Administrative Finance, LLC and Post Road Special Opportunity Fund I LLP (incorporated by reference to Exhibit 10.38 to Pareteum Corporation’s Annual Report on Form 10-K filed on March 18, 2019)
|
|
|
|
10.39***
|
|
Security Agreement between Pareteum Corporation and certain subsidiaries of Pareteum Corporation, Post Road Administrative Finance, LLC and Post Road Special Opportunity Fund I LLP (incorporated by reference to Exhibit 10.39 to Pareteum Corporation’s Annual Report on Form 10-K filed on March 18, 2019)
|
|
|
|
10.40***
|
|
Patent Security Agreement between Pareteum Corporation and certain subsidiaries of Pareteum Corporation, Post Road Administrative Finance, LLC and Post Road Special Opportunity Fund I LLP (incorporated by reference to Exhibit 10.40 to Pareteum Corporation’s Annual Report on Form 10-K filed on March 18, 2019)
|
|
|
|
10.41***
|
|
Trademark Security Agreement between Pareteum Corporation and certain subsidiaries of Pareteum Corporation, Post Road Administrative Finance, LLC and Post Road Special Opportunity Fund I LLP (incorporated by reference to Exhibit 10.41 to Pareteum Corporation’s Annual Report on Form 10-K filed on March 18, 2019)
|
|
|
|
21.1
|
|
Subsidiaries (incorporated by reference to Exhibit 21.1 to Pareteum Corporation’s Annual Report on Form 10-K filed on March 18, 2019)
|
|
|
|
23.1*
|
|
Consent of Sichenzia
Ross Ference LLP (Included in the opinion filed as Exhibit 5.1)
|
|
|
|
23.2*
|
|
Consent of Squar Milner LLP
|
|
|
|
23.3*
|
|
Consent of Grant Thornton LLP
|
|
|
|
23.4*
|
|
Consent of BDO USA LLP
|
*
|
Filed Herewith
|
**
|
Employee Compensation Plan
|
***
|
Confidential Treatment has been granted for certain portions of this Exhibit.
|
SIGNATURES
Pursuant to the requirements of the
Securities Act of 1933, as amended, the registrant certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned,
thereunto duly authorized, in New York, New York on August 16, 2019.
|
Pareteum Corporation
|
|
|
|
|
|
By:
|
/s/ Robert H. Turner
|
|
|
Name:
|
Robert H. Turner
|
|
|
Title:
|
Chief Executive Officer and Executive Chairman
(Principal Executive Officer)
|
Pursuant to the requirements
of the Securities Act of 1933, as amended, this Registration Statement has been signed by the following persons in the capacities
and on the date indicated.
/s/
Robert H. Turner
|
|
Chief
Executive Officer and Executive Chairman
|
|
August
16, 2019
|
Robert H. Turner
|
|
(Principal Executive
Officer)
|
|
|
|
|
|
|
|
/s/
Edward O’Donnell
|
|
Chief Financial
Officer
|
|
August 16, 2019
|
Edward O’Donnell
|
|
(Principal Financial
and Accounting Officer)
|
|
|
|
|
|
|
|
/s/
*
|
|
Director
|
|
August 16, 2019
|
Yves van Sante
|
|
|
|
|
|
|
|
|
|
/s/
*
|
|
Director
|
|
August 16, 2019
|
Luis Jimenez-Tuñon
|
|
|
|
|
|
|
|
|
|
/s/
*
|
|
Director
|
|
August 16, 2019
|
Robert Lippert
|
|
|
|
|
*By:
|
/s/
Robert H. Turner
|
|
As Attorney-in-Fact
|
|
August 16, 2019
|
|
Robert
H. Turner
|
|
|
|
|
Pareteum (NASDAQ:TEUM)
Historical Stock Chart
From Mar 2024 to Apr 2024
Pareteum (NASDAQ:TEUM)
Historical Stock Chart
From Apr 2023 to Apr 2024